Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01BX004743-01 |
| Title: | Development of dihydrocaffeic acid and malvidin- 3 - glucoside for the treatment of depression and anxiety disorders |
| Principal Investigator: | Jun Wang |
| Location: | Bronx, NY |
| Congressional District Code: | 13 |
| Research Service: | Biomedical Laboratory R&D |
| Project Period: | October 2019 - September 2023 |
| FY 2021 Funding Amount: | $231,227 |
| Total Award Amount (all years): |
$993,157 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Depression, anxiety, and other stress-related disorders are widespread psychological conditions with broad health implications, including negative impacts on cardiovascular and metabolic functions and on mental health, including memory dysfunction. The prevalence of depression is even higher in veterans. It was estimated that approximately 30% of Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) veterans are affected by depression. Current available treatments for depression mai... |